Raging the war against inflammation with natural products A Attiq, J Jalil, K Husain, W Ahmad Frontiers in pharmacology 9, 412989, 2018 | 195 | 2018 |
New insights into molecular mechanism behind anti-cancer activities of lycopene BP Puah, J Jalil, A Attiq, Y Kamisah Molecules 26 (13), 3888, 2021 | 71 | 2021 |
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19 A Attiq, LJ Yao, S Afzal, MA Khan International immunopharmacology 101, 108255, 2021 | 70 | 2021 |
Annonaceae: breaking the wall of inflammation A Attiq, J Jalil, K Husain Frontiers in pharmacology 8, 752, 2017 | 52 | 2017 |
Luteolin and apigenin derived glycosides from Alphonsea elliptica abrogate LPS-induced inflammatory responses in human plasma A Attiq, J Jalil, K Husain, HF Mohamad, A Ahmad Journal of ethnopharmacology 275, 114120, 2021 | 30 | 2021 |
The medicinal uses, toxicities and anti-inflammatory activity of Polyalthia species (Annonaceae) LJ Yao, J Jalil, A Attiq, CC Hui, NA Zakaria Journal of ethnopharmacology 229, 303-325, 2019 | 30 | 2019 |
Modulation of inflammatory pathways, medicinal uses and toxicities of Uvaria species: potential role in the prevention and treatment of inflammation J Jalil, A Attiq, CC Hui, LJ Yao, NA Zakaria Inflammopharmacology 28, 1195-1218, 2020 | 14 | 2020 |
Antibacterial activity of essential oils extracted from medicinal plants against multi-drug resistant Staphylococcus aureus. SA Raja, M Ashraf, AA Anjum, A Javeed, T Ijaz, A Attiq | 12 | 2016 |
Enhancement of anti-proliferative activities of Metformin, when combined with Celecoxib, without increasing DNA damage A Ullah, M Ashraf, A Javeed, AA Anjum, A Attiq, S Ali Environmental toxicology and pharmacology 45, 227-234, 2016 | 10 | 2016 |
Hegemony of inflammation in atherosclerosis and coronary artery disease A Attiq, S Afzal, W Ahmad, M Kandeel European journal of pharmacology, 176338, 2024 | 7 | 2024 |
From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration S Afzal, AS Abdul Manap, A Attiq, I Albokhadaim, M Kandeel, SM Alhojaily Frontiers in Pharmacology 14, 1269581, 2023 | 7 | 2023 |
Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats S Afzal, MA Sattar, EJ Johns, OA Eseyin, A Attiq PPAR research 2021, 2021 | 6 | 2021 |
A new prenylated benzoquinone from Cyathocalyx pruniferus abrogates LPS-induced inflammatory responses associated with PGE2, COX-2 and cytokines … A Attiq, J Jalil, K Husain, JA Jamal, EN Ismail Inflammopharmacology 29, 841-854, 2021 | 5 | 2021 |
Crosstalk relationship between adiponectin receptors, PPAR-γ and α-adrenoceptors in renal vasculature of diabetic WKYs S Afzal, MA Sattar, OA Eseyin, A Attiq, EJ Johns European journal of pharmacology 917, 174703, 2022 | 3 | 2022 |
Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment A Attiq, S Afzal Frontiers in pharmacology 14, 1255727, 2023 | 2 | 2023 |
Augmented cytotoxic, mutagenic and genotoxic response triggered by carvedilol and celecoxib combinations A Attiq, M Ashraf, J Jalil, A Javeed, AA Anjum, A Ullah, M Umair, S Ali Brazilian Journal of Pharmaceutical Sciences 54, e17292, 2018 | 2 | 2018 |
Platinum-based targeted chemotherapies and reversal of cisplatin resistance in non-small cell lung cancer (NSCLC) H Umar, HA Wahab, A Attiq, MW Amjad, SNA Bukhari, W Ahmad Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 111856, 2024 | | 2024 |
Full PPAR-γ Agonist With Adiponectin Abrogates Oxidative Stress. S Afzal, MA Sattar, A Attiq, A Velaga Malaysian Journal of Medicine & Health Sciences 18, 2022 | | 2022 |